Literature DB >> 28627662

MicroRNA-363-3p is downregulated in hepatocellular carcinoma and inhibits tumorigenesis by directly targeting specificity protein 1.

Jie Ying1, Xuechun Yu1, Chaojian Ma1, Yongqi Zhang1, Jingwu Dong1.   

Abstract

microRNAs exhibit important regulatory roles in tumorigenesis and tumor development, such as in hepatocellular carcinoma (HCC). The present study aimed to investigate the expression and functional roles of microRNA (miR)‑363‑3p in HCC. miR-363-3p expression levels in a number of HCC tissues and cell lines were measured by reverse transcription-quantitative PCR (RT‑qPCR). The effects of miR‑363‑3p expression on HCC cell proliferation, migration and invasion were exa-mined by MTT assay, Transwell migration and invasion assay, respectively. The effects of miR‑363‑3p on its downstream target gene, specificity protein 1 (SP1), were examined by bioinformatics analysis, luciferase reporter assay, RT‑qPCR and western blotting. An SP1 overexpression vector was subsequently transfected into HCC cells to assess any selective effects on miR‑363‑3p in modulating HCC. The results revealed that miR‑363‑3p expression levels were downregulated in both HCC tissues and cell lines, and this low expression level was correlated with tumor size, tumor‑node‑metastasis stage and venous infiltration in patients with HCC. Upregulation of miR‑363‑3p inhibited cell proliferation, migration and invasion in HCC cell cultures. In HCC cells transfected with an SP1 expression vector the miR‑363‑3p‑induced tumor suppressive roles on cell proliferation, migration and invasion were reversed. In conclusion, results from the present study indicated that miR‑363‑3p is a tumor suppressor in HCC and functions through a mechanism involving SP1, suggesting that miR‑363‑3p may be a potential new therapeutic target for the treatment of HCC.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28627662     DOI: 10.3892/mmr.2017.6759

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  10 in total

1.  Long noncoding RNA NNT-AS1 promotes hepatocellular carcinoma progression and metastasis through miR-363/CDK6 axis.

Authors:  Ye-Bin Lu; Qin Jiang; Man-Yi Yang; Ji-Xiang Zhou; Qi Zhang
Journal:  Oncotarget       Date:  2017-09-28

2.  Spatiotemporal microRNA profile in peripheral nerve regeneration: miR-138 targets vimentin and inhibits Schwann cell migration and proliferation.

Authors:  Travis B Sullivan; Litchfield C Robert; Patrick A Teebagy; Shannon E Morgan; Evan W Beatty; Bryan J Cicuto; Peter K Nowd; Kimberly M Rieger-Christ; David J Bryan
Journal:  Neural Regen Res       Date:  2018-07       Impact factor: 5.135

3.  MiR-92a Family: A Novel Diagnostic Biomarker and Potential Therapeutic Target in Human Cancers.

Authors:  Min Jiang; Xuelian Li; Xiaowei Quan; Xiaoying Li; Baosen Zhou
Journal:  Front Mol Biosci       Date:  2019-10-01

4.  MicroRNA‑363‑3p inhibits hepatocarcinogenesis by targeting HMGA2 and is associated with liver cancer stage.

Authors:  Jing Wang; Huimin Liang; Haize Ge; Xinling Guo; Dongmei Gu; Yuhua Yuan
Journal:  Mol Med Rep       Date:  2018-11-29       Impact factor: 2.952

Review 5.  The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis.

Authors:  Kurt Sartorius; Julia Makarova; Benn Sartorius; Ping An; Cheryl Winkler; Anil Chuturgoon; Anna Kramvis
Journal:  Cells       Date:  2019-11-24       Impact factor: 6.600

6.  The circular RNA circ0005654 interacts with specificity protein 1 via microRNA-363 sequestration to promote gastric cancer progression.

Authors:  Cui Yang; Shengjin Han
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

7.  Effects of miR-363 on the Biological Activities of Eutopic Endometrial Stromal Cells in Endometriosis.

Authors:  Manman Nai; Yingying Zhang; Lei Li; Yuxi Jin; Yangge Li; Luwen Wang; Chenchen Ren
Journal:  Biomed Res Int       Date:  2022-03-26       Impact factor: 3.411

8.  Exosomal miR-638 Inhibits Hepatocellular Carcinoma Progression by Targeting SP1.

Authors:  Jing Yang; Bo Li; Shuo Zhao; Hongyu Du; Yaming Du
Journal:  Onco Targets Ther       Date:  2020-07-07       Impact factor: 4.147

Review 9.  The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways.

Authors:  Kurt Sartorius; Leo Swadling; Ping An; Julia Makarova; Cheryl Winkler; Anil Chuturgoon; Anna Kramvis
Journal:  Viruses       Date:  2020-07-10       Impact factor: 5.818

10.  Circulating exosomal miR-363-5p inhibits lymph node metastasis by downregulating PDGFB and serves as a potential noninvasive biomarker for breast cancer.

Authors:  Xin Wang; Tianyi Qian; Siqi Bao; Hengqiang Zhao; Hongyan Chen; Zeyu Xing; Yalun Li; Menglu Zhang; Xiangzhi Meng; Changchang Wang; Jie Wang; Hongxia Gao; Jiaqi Liu; Meng Zhou; Xiang Wang
Journal:  Mol Oncol       Date:  2021-06-25       Impact factor: 6.603

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.